Evidence map›Paper›PMID 42533876›Full record

ArticleJournal of military, veteran and family health2023

Studying classic psychedelics for the management of headache disorders: Considerations for Veterans.

Emmanuelle A D Schindler, Jason J Sico

Abstract read
In one paragraph

Article in Journal of military, veteran and family health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emmanuelle A D SchindlerVeterans Health Administration Headache Centers of Excellence, West Haven, Connecticut, United States.
Jason J SicoVeterans Health Administration Headache Centers of Excellence, West Haven, Connecticut, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Headache disorders, such as migraine and cluster headache, are common conditions that are accompanied by significant disability and poor quality of life. Military members and Veterans are at increased risk of developing headache disorders, particularly in the context of traumatic brain injury. Although there are several treatment options for headache management, poor efficacy, tolerability, or access limit their success, and there is always a need to identify new treatments in headache medicine. The therapeutic effects of psychedelic drugs for headache disorders have been reported for decades. Unlike conventional treatment options, psychedelics are reported to have lasting (weeks, months) therapeutic effects after limited dosing (single or few doses). Controlled trials of psilocybin and lysergic acid diethylamide are emerging. Recently published studies of psilocybin in migraine and cluster headache are reviewed in this article. Although anecdotal evidence is generally supported, more research is required before the safety and efficacy of psychedelic drugs for headache disorders can be verified. Veterans have been active in emerging research with psychedelics, although safety and cultural concerns may preclude some in this population from participating.

Indexed as

cluster headacheheadache disordersLSDlysergic acid diethylamidemigrainemilitarypsilocybinpsychedelicsVeterans

Identifiers

PMID42533876
PMCPMC13292876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.